| CTRI Number |
CTRI/2024/07/069732 [Registered on: 01/07/2024] Trial Registered Prospectively |
| Last Modified On: |
01/07/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Comparison of effectiveness of 2 injections Dexmedetomidine and Labetalol in managing increase in blood pressure and heart rate occuring during passage of breathing tube into windpipe in patients coming for planned surgery before
general anesthesia |
|
Scientific Title of Study
|
A Comparative study of dexmedetomidine and labetalol for attenuating hemodynamic response to laryngoscopy and intubation in patients coming for elective surgeries under general anaesthesia |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Harikrishna S |
| Designation |
Junior Resident |
| Affiliation |
Rajendra Institute of Medical Sciences |
| Address |
Department of Anaesthesia,Rajendra Institute of Medical Sciences,Bariatu,Ranchi,Jharkhand,Pincode-834009,India
Ranchi JHARKHAND 834009 India |
| Phone |
7907217423 |
| Fax |
|
| Email |
harinakshatra16@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Praveen Kumar Tiwary |
| Designation |
Associate Professor |
| Affiliation |
Rajendra Institute of Medical Sciences |
| Address |
Department of Anaesthesiology RIMS Ranchi
JHARKHAND
834009
India
Ranchi JHARKHAND 834009 India |
| Phone |
9661883797 |
| Fax |
|
| Email |
drpkt80@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Ramesh Kumar Kharwar |
| Designation |
Assistant Professor |
| Affiliation |
Rajendra Institute of Medical Sciences |
| Address |
Department of Anaesthesiology RIMS Ranchi
JHARKHAND
834009
India
Ranchi JHARKHAND 834009 India |
| Phone |
8294044274 |
| Fax |
|
| Email |
rameshrims02@yahoo.in |
|
|
Source of Monetary or Material Support
|
| Rajendra Institute of Medical Sciences,Bariatu,Ranchi,Jharkhand,pincode-834009 |
|
|
Primary Sponsor
|
| Name |
Rajendra Institute of Medical Sciences |
| Address |
Rajendra Institute of Medical Sciences,Bariatu,Ranchi,Jharkhand,pincode-834009 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Harikrishna S |
Rajendra Institute of Medical Sciences |
Department
of anaesthesia,Bariatu,Ranchi,Jharkhand Ranchi JHARKHAND |
7907217423
harinakshatra16@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee, Rajendra Institute of Medical Sciences, Ranchi |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
intravenous dexmedetomidine |
injection Dexmedetomidine is given at a dose of 1 µg/kg in 10ml normal saline intravenously over 10 minutes |
| Comparator Agent |
intravenous labetalol |
injection labetalol is given at a dose of 0.3 mg/kg in 10ml normal saline intravenously over 10 minutes |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
ASA Grade I & II ,Elective surgery requiring general anesthesia with endotracheal intubation |
|
| ExclusionCriteria |
| Details |
Patient contraindicated to beta blockers,Hypertensive patients,patients on anti hypertensives,Systolic BP less than 120 mm of hg , HR less than 60/min,Evidence of anticipated difficult airway,Drug allergy to dexmedetomidine and labetalol,Pregnant patients,Ischemic heart disease,Cerebrovascular accidents,patient refusal,intubation attempts more than 2 times |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
To compare the efficacy of dexmedetomidine 1 µg/kg and labetalol 0.3
mg/kg in blunting the hemodynamic stress response to laryngoscopy and intubation |
1)after drug administration
2)after induction
3)1 minute after induction
4)2 minute after induction
5)3 minute after induction
6)5 minute after induction
7)10 minute after induction
8)15 minute after induction |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1)To observe for any adverse effect related to dexmedetomidine and
labetalol
2)To determine and compare the level of sedation achieved before intubation after administration
of dexmedetomidine and labetalol |
1)after drug administration
2)after induction
3)1 minute after induction
4)2 minute after induction
5)3 minute after induction
6)5 minute after induction
7)10 minute after induction
8)15 minute after induction |
|
|
Target Sample Size
|
Total Sample Size="108" Sample Size from India="108"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
31/07/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The process of endotracheal intubation, commonly used in various medical procedures, plays a crucial role in ensuring adequate ventilation and oxygenation of patients. However, this procedure can also induce significant physiological changes, particularly in the cardiovascular system, leading to hemodynamic instability. Understanding the hemodynamic changes during intubation is of paramount importance for healthcare professionals to effectively manage and minimize the associated risks.General anesthesia with endotracheal intubation is very common now a days. Endotracheal intubation using direct laryngoscopes is associated with stimulation of trachea and larynx. This will result in tachycardia and rise in blood pressure .Eventhough the responses are short lived and causes less consequences in healthy patients. These changes can be fatal in patients with preexisting heart disease, hypertension or cerebrovascular condition, complications like left ventricular failure, intracranial hemorrhage and myocardial ischemia can occur as a result of tachycardia and sudden rise in blood pressure. Under such circumstances it becomes a necessity to attenuate such reflex responses associated with endotracheal intubation and laryngoscopy to achieve a balance between the myocardial oxygen supply and demand.Common strategies include deepening the depth of anesthesia, topical anaesthesia of the oropharynx, intravenous lignocaine, intravenous fentanyl, alfentanil, sodium nitroprusside, beta adrenergic blocking drugs, alpha-2-adrenergic agonists, calcium channel blockers etc.The advantages of Dexmedetomidine as premedicant in anaesthesia include sedation, analgesia, anxiolysis and improved hemodynamic stability. Because of these beneficial properties it has been found that minimum alveolar concentration (MAC) of volatile anaesthetic agent also decreases significantly up to 90% and hence decreases the requirement of anaesthetics.It has been found that it decrease the hemodynamic response to laryngoscopy and intubation.Labetalol is combined α1andβ antagonist and pre induction intravenous labetalol attenuated the hemodynamic response to endotracheal intubation.Labetalol is suitable for blunting the hemodynamic changes associated with laryngoscopy and intubationThis study between comparison of IV dexmedetomidine and IV labetalol aims at finding out which drug is better at blunting the stress response associated with laryngoscopy and intubation. |